Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,272 | 1,754 | 1,344 | 530 | 651 |
| Marketable Securities | 32 | 31 | 33 | 31 | 30 |
| Receivables | 57 | 40 | 37 | 34 | 53 |
| TOTAL | $1,550 | $2,136 | $1,676 | $668 | $774 |
| Non-Current Assets | |||||
| PPE Net | 0 | 1 | 2 | 1 | 1 |
| Intangibles | 37 | 40 | 49 | 51 | 54 |
| TOTAL | $37 | $42 | $51 | $52 | $55 |
| Total Assets | $1,587 | $2,178 | $1,726 | $720 | $829 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 90 | 85 |
| Accounts payable and accrued liabilities | 1,118 | 523 | 207 | 578 | 312 |
| Accrued Expenses | 165 | 344 | 299 | N/A | N/A |
| Other current liabilities | N/A | 462 | N/A | N/A | N/A |
| TOTAL | $1,283 | $1,329 | $507 | $668 | $397 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,283 | $1,329 | $507 | $668 | $397 |
| Shareholders' Equity | |||||
| Common Shares | 37,536 | 33,203 | 29,799 | 24,337 | 21,957 |
| Retained earnings | -50,208 | -42,722 | -38,189 | -31,249 | -27,778 |
| Other shareholders' equity | 6,796 | 4,502 | 3,302 | 1,102 | 1,000 |
| TOTAL | $305 | $849 | $1,219 | $52 | $432 |
| Total Liabilities And Equity | $1,587 | $2,178 | $1,726 | $720 | $829 |